RAFAEL HOLDINGS, INC. Cash and Restricted Cash
RAFAEL HOLDINGS, INC. (RFL) had Cash and Restricted Cash of $30.50 million as of 2026-04-30, per its 10-Q filed 2026-06-11.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-06-11
- 2026-04-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $30.50M.
- 2026-01-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $37.78M.
- 2025-10-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $45.54M.
- 2025-07-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $52.77M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-04-30 | $30.50M 10-Q · filed 2026-06-11 |
| 2026-01-31 | $37.78M 10-Q · filed 2026-03-16 |
| 2025-10-31 | $45.54M 10-Q · filed 2025-12-12 |
| 2025-07-31 | $52.77M 10-Q · filed 2026-06-11 |
| 2025-04-30 | $37.94M 10-Q · filed 2026-06-11 |
| 2025-01-31 | $48.32M 10-Q · filed 2026-03-16 |
| 2024-10-31 | $8.16M 10-Q · filed 2025-12-12 |
| 2024-07-31 | $2.67M 10-Q · filed 2026-06-11 |
| 2024-04-30 | $7.44M 10-Q · filed 2025-06-11 |
| 2024-01-31 | $7.14M 10-Q · filed 2025-03-14 |
| 2023-10-31 | $13.20M 10-Q · filed 2024-12-11 |
| 2023-07-31 | $21.50M 10-K · filed 2025-10-29 |
| 2023-04-30 | $15.44M 10-Q · filed 2024-06-14 |
| 2023-01-31 | $9.67M 10-Q · filed 2024-03-14 |
| 2022-10-31 | $22.83M 10-Q · filed 2023-12-14 |
| 2022-07-31 | $26.54M 10-K/A · filed 2024-12-20 |
| 2022-04-30 | $28.96M 10-Q · filed 2023-06-13 |
| 2022-01-31 | $70.03M 10-Q · filed 2023-03-14 |
| 2021-10-31 | $77.39M 10-Q · filed 2022-12-13 |
| 2021-07-31 | $12.85M 10-K · filed 2023-10-30 |
| 2021-04-30 | $4.68M 10-Q · filed 2022-06-14 |
| 2021-01-31 | $6.09M 10-Q · filed 2022-03-17 |
| 2020-07-31 | $6.21M 10-K · filed 2022-10-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |